LRRK2 and Parkinson disease: It has been reported that dynamin 3 (DNM3) may be a potential genetic modifier in the relationship between LRRK2 and age-dependent penetrance in LRRK2-associated PD in Arab-Berber patients (Trinh et al., 2016).